Education and experience:
Dr Helga Gardarsdottir is an associate professor of Drug Regulatory Sciences at the Division of Pharmacoepidemiology & Clinical Pharmacology. She was trained as a pharmacist at Uppsala University in Sweden and worked for two years at the International Pharmaceutical Federation (FIP) in The Hague following her graduation. Helga obtained her PhD in pharmacoepidemiology from Utrecht University in 2009 with a thesis entitled “Drug treatment episodes in pharmacoepidemiology: Antidepressants as a model”. Between 2009 and 2017 she worked as a post-doc and later as assistant professor at the department of Clinical Pharmacy at University Medical Center Utrecht.
Her primary research interests include the application and development of tools and approaches to evaluate the consequences of regulatory decision making and to improve robustness of pharmacoepidemiological safety studies used in benefit-risk evaluations. Further, her interests involve assessing safety of therapies with a special focus on biopharmaceutical products.